Baxter targets 5%-6% 2025 revenue growth amid Novum IQ pump success and operational recovery
Q4 2024 Management View Interim CEO Brent Shafer highlighted the completion of the Vantive sale as a significant milestone in Baxter's transformation strategy and noted the company's focus on ...
Following Hurricane Helene, Baxter doesn’t expect to return to normal supply of IV fluids until end of 2024
Baxter said in a statement Wednesday that its goal is to return to 90% to 100% allocation of certain IV solutions by the end ...
Crain's Chicago Business5h
Baxter stock surges as earnings beat Wall Street estimates
Following the completion of a massive restructuring plan, the medical equipment giant projects 4% to 5% sales growth this ...
MassDevice3h
Baxter stock rises on Street-beating, better-than-expected Q4
The Deerfield, Illinois-based medtech company reported losses of $512 million. That equals $1 per share on sales of $2.75 ...